Mutual effect modification between adiponectin and HDL as risk factors of cardiovascular events in Type 2 diabetes individuals: a cohort study.

Stefanos RoumeliotisVasillios LiakopoulosAthanasios RoumeliotisAikaterini StamouStylianos PanagoutsosGraziella D'ArrigoGiovanni Tripepi

Published in: International urology and nephrology (2021)

Our results are coherent with the hypothesis that HDL cholesterol might play a pivotal role in the interpretation of the association between adiponectin and the risk of adverse CV outcomes in this population.

Keyphrases

cardiovascular events
type diabetes
risk factors

insulin resistance
cardiovascular disease
coronary artery disease

metabolic syndrome
glycemic control
adipose tissue

weight loss
adverse drug